Here are relevant reports on : in-vivo-cro-market
-
Chromatography Columns Market by Column Type (Ion Exchange, Size Exclusion, Reverse and Normal Phases, HPLC, Affinity, Chiral), Capacity (1-100 ml, 100-1000 ml, >1 liter), End User (Pharma & Biotech, CRO, CDMO) - Global Forecast to 2031
The global chromatography columns market, valued at US$2.58 billion in 2024, stood at US$2.77 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2031, culminating in a forecasted valuation of US$4.22 billion by the end of the period. The chromatography columns market is evolving from a fragmented consumables segment into a strategically critical component of analytical and clinical laboratory workflows, driven by the increasing demand for reproducibility, method standardization, and high-throughput performance across regulated environments.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Healthcare Data Storage Market by Delivery (Remote, Hybrid, On-premise), Architecture (File, Block, Object), Type (Tape, Flash, Solid), Systems (Direct, Network), End User (Pharma, Biotech, CRO, Hospital, Clinic, Research Center) - Global Forecasts to 2024
The global healthcare data storage market size is projected to reach USD 5.4 billion in 2024, at a CAGR of 14.3%. Some of the prominent players offering in this market are Dell (US), IBM Corporation (US), NetApp (US), Hewlett Packard Enterprise Development LP (US), Pure Storage, Inc. (US), Hitachi, Ltd. (Japan), Toshiba Corporation (Japan), Western Digital Corporation (US), Scality (US), and Huawei Technologies Co., Ltd. (China).
- Published: October 2019
- Price: $ 4950
- TOC Available:
-
Residual DNA Testing Market by Product & Service (Consumable, Instrument & Software), Technology (PCR), Test Type (Raw, Final, Bulk Lot Release Testing), Application (mAb, CGT, Vaccine), End User (Pharma & Biotech, CRO & CDMO) - Global Forecast to 2030
The global residual DNA testing market, valued at US$0.27 billion in 2024, stood at US$0.28 billion in 2025 and is projected to advance at a resilient CAGR of 6.0% from 2025 to 2030, culminating in a forecasted valuation of US$0.37 billion by the end of the period. The growth of the Asia Pacific residual DNA testing market is primarily due to increasing number of fundings and investments by pharmaceutical and biotechnology companies for the advancement of the healthcare sector. Additionally, emerging markets in the Asia Pacific is set to enhance the residual DNA testing market growth.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
AI in Protein Engineering Market by AI Tools (Generative, Protein Language, Structure-Based), Application (Binder, De Novo, Enzyme Engineering), Protein Type (Antibody, Peptide), Process (Discovery, Design), End User (CRO, Pharma) – Global Forecast to 2031
The global AI in protein engineering market is projected to reach USD 3.82 billion by 2031, growing at a CAGR of 21.6% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Aseptic Sampling Market by Type (Manual [Type (Traditional, Single-use), Product (Bags, Bottles, Syringes, Accessories)], Automatic), Application (Upstream, Downstream), Technique (Off-line, On-line), End User (R&D, CMO, CRO) - Global Forecast to 2025
The global aseptic sampling market is projected to reach USD 474 million by 2025 from USD 264 million in 2020, at a CAGR of 12.4%. Market growth is driven mainly by the increasing demand for biopharmaceuticals, stringent government regulations to ensure drug safety, and funding to support life sciences research activities.
- Published: June 2020
- Price: $ 4950
- TOC Available:
-
AI in Clinical Trials Market by Function (Patient Recruitment, Site Optimization, Data Management, Quality, Regulatory), Phase (I, II, III), Indication (Cancer, CNS, CVS), Tool, End-User (Pharma/Biotech, CRO, Hospitals) & Region - Global Forecast to 2030
The global AI in clinical trials market, valued at US$1.20 billion in 2023, stood at US$1.35 billion in 2024 and is projected to advance at a resilient CAGR of 12.4% from 2024 to 2030, culminating in a forecasted valuation of US$2.74 billion by the end of the period. The AI in clinical trials market is experiencing significant growth driven by increasing demand for patient-centred and patient-driven situated trials, where AI improves remote monitoring of patients along with improving retention and recruitment of patients.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Analytics), Phase, Trial (Decentralized), Therapy (Onco, Cardio, Neuro, Rare Disease), End User (CRO, Pharma & Biotech) - Forecast to 2031
The global eClinical solutions market is projected to reach USD 31.32 billion by 2031, growing at a CAGR of 14.7% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Clinical Laboratory Services Market by Specialty (Biochemistry, Endocrinology, Microbiology, Hematology, Cytology, Histopathology, Genetic Testing), Providers (Independent Laboratory, Reference Laboratory, Hospital Laboratory) & Geography - Global Forecast to 2022
The clinical laboratory services market is expected to reach USD 146.41 billion by 2022 from USD 113.4 billion in 2017, at a CAGR of 5.2% during the forecast period. The major players in the market are Mayo Medical Laboratories (US), Laboratory Corporation of America Holdings (US), Quest Diagnostics Incorporated (US), Spectra Laboratories Inc. (US), DaVita Healthcare Partners (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Bio-Reference Laboratories (US), Sonic Healthcare (UK), Cerba HealthCare (France), and among others
- Published: December 2017
- Price: $ 4950
- TOC Available:
-
Outlook of Cardiac Pacemaker Market - Global Forecasts (2011-2016)
Pacemaker devices constitute a major segment in a rapidly expanding cardiovascular devices market. The global cardiac pacemakers market is characterized by relatively mature conditions and intense competition. However, an aging global population, and the subsequent rise in the incidence of cardiovascular diseases, has ensured a steady growth for the pacemakers market.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Erectile Dysfunction, Premature Ejaculation & Alopecia Market - Global Forecasts (2011-2016)
The development of erectile dysfunction is associated with an underlying cause which is organic in nature. Drug induced causes of erectile dysfunction are common and can complicate the medical management of underlying conditions such as hypertension, depression, and BPH. Beta blockers, selective serotonin reuptake inhibitors (SSRIs), and the uroselective alpha adrenergic receptor antagonists have been associated with the loss of libido or ejaculatory disorders, which can result in drug discontinuation by patients and suboptimal treatment of these conditions.
- Published: December 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
